RMTI
ROCKWELL MEDICAL, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$8.07
+1.96%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.13
- Revenue estimate
- $18.2M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.34
- EPS estimate
- -$0.23
- Revenue actual
- $17.8M
- Revenue estimate
- $17.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -123.7%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.23 | -$0.34 | Miss -44.68% | $17.8M |
| May 7, 2026 | -$0.01 | -$0.04 | Miss -300.00% | $17.3M |
| Mar 26, 2026 | $0.04 | -$0.01 | Miss -125.00% | $18.3M |
| Nov 12, 2025 | -$0.04 | -$0.05 | Miss -25.00% | $15.9M |
| Aug 14, 2025 | -$0.05 | -$0.05 | In line | $16.1M |
| Mar 20, 2025 | $0.02 | -$0.02 | Miss -200.00% | $24.7M |
| Aug 8, 2024 | $0.00 | $0.01 | Beat 125.73% | $25.8M |
| Mar 21, 2024 | -$0.08 | $0.02 | Beat 125.00% | $22.1M |
| Nov 14, 2023 | -$0.12 | -$0.07 | Beat 41.67% | $23.8M |
| Aug 14, 2023 | -$0.12 | -$0.18 | Miss -50.00% | $18.1M |
| May 15, 2023 | -$0.18 | -$0.10 | Beat 44.44% | $19.7M |
| Nov 14, 2022 | -$0.37 | -$0.40 | Miss -8.11% | $18.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026